The Metabolic Oncolytic Regimen is a complex cancer treatment program that encourages solid tumors with specific mutations to the p53 gene to become so acidic as undergo lysis (die off). This approach was pioneered by Dr. Anthony G. Payne based (in part) on work done by former NASA scientist, Clarence Cone, Jr., Ph.D. (dec).
The Metabolic Oncolytic Regimen was first published during 1996. A revised version was made available during 2001.
External link